-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Cullinan Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2021 to Q2 2024.
- Cullinan Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $10.5M, a 33% increase year-over-year.
- Cullinan Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $34M, a 21.7% increase year-over-year.
- Cullinan Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $30.4M, a 8.87% increase from 2022.
- Cullinan Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $28M, a 14.7% increase from 2021.
- Cullinan Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $24.4M, a 63.5% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)